| Primary |
| Hiv Infection |
75.3% |
| Tuberculosis |
3.1% |
| Product Used For Unknown Indication |
2.6% |
| Hypertension |
2.5% |
| Prophylaxis |
2.3% |
| Drug Exposure During Pregnancy |
2.1% |
| Prophylaxis Against Hiv Infection |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Antifungal Prophylaxis |
1.5% |
| Depression |
1.5% |
| Mycobacterium Avium Complex Infection |
0.8% |
| Pulmonary Tuberculosis |
0.7% |
| Opportunistic Infection Prophylaxis |
0.6% |
| Ischaemic Cardiomyopathy |
0.5% |
| Pain |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Hepatitis B |
0.5% |
| Diabetes Mellitus |
0.5% |
| Hepatitis C |
0.5% |
| Antiretroviral Therapy |
0.4% |
|
| Abortion Spontaneous |
12.6% |
| Renal Failure Acute |
11.8% |
| Renal Failure |
9.1% |
| Pregnancy |
7.8% |
| Ultrasound Antenatal Screen Abnormal |
7.0% |
| Vomiting |
7.0% |
| Osteonecrosis |
4.9% |
| Death |
4.1% |
| Weight Decreased |
3.8% |
| Stevens-johnson Syndrome |
3.6% |
| Stillbirth |
3.6% |
| Renal Tubular Disorder |
3.2% |
| Fanconi Syndrome Acquired |
3.0% |
| Immune Reconstitution Syndrome |
2.9% |
| Renal Impairment |
2.9% |
| Rhabdomyolysis |
2.8% |
| Thrombocytopenia |
2.8% |
| Renal Tubular Necrosis |
2.6% |
| Pyrexia |
2.5% |
| Suicidal Ideation |
2.3% |
|
| Secondary |
| Hiv Infection |
55.5% |
| Drug Exposure During Pregnancy |
8.2% |
| Product Used For Unknown Indication |
7.5% |
| Antiretroviral Therapy |
5.7% |
| Drug Use For Unknown Indication |
4.3% |
| Maternal Exposure Timing Unspecified |
4.0% |
| Antiviral Treatment |
2.0% |
| Prophylaxis |
1.9% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Hypertension |
1.4% |
| Hiv Test Positive |
1.3% |
| Tuberculosis |
1.1% |
| Hepatitis C |
1.0% |
| Prophylaxis Against Hiv Infection |
0.9% |
| Maternal Exposure During Pregnancy |
0.8% |
| Depression |
0.6% |
| Human Immunodeficiency Virus Transmission |
0.6% |
| Pain |
0.6% |
| Insomnia |
0.5% |
| Pneumocystis Jiroveci Pneumonia |
0.5% |
|
| Abortion Spontaneous |
10.3% |
| Pregnancy |
9.0% |
| Drug Exposure During Pregnancy |
8.4% |
| Renal Failure Acute |
7.8% |
| Premature Baby |
6.9% |
| Vomiting |
6.1% |
| Renal Failure |
5.2% |
| Foetal Exposure During Pregnancy |
5.0% |
| Thrombocytopenia |
4.2% |
| Maternal Exposure During Pregnancy |
3.9% |
| Pyrexia |
3.9% |
| Weight Decreased |
3.9% |
| Immune Reconstitution Syndrome |
3.7% |
| Stillbirth |
3.4% |
| Rash |
3.3% |
| Ventricular Septal Defect |
3.1% |
| Osteonecrosis |
3.1% |
| Rhabdomyolysis |
3.1% |
| Umbilical Cord Abnormality |
2.9% |
| Sepsis |
2.8% |
|
| Concomitant |
| Hiv Infection |
56.6% |
| Product Used For Unknown Indication |
9.7% |
| Drug Use For Unknown Indication |
9.6% |
| Hepatitis C |
4.7% |
| Hypertension |
2.2% |
| Acquired Immunodeficiency Syndrome |
1.9% |
| Depression |
1.9% |
| Prophylaxis |
1.7% |
| Tuberculosis |
1.7% |
| Drug Exposure During Pregnancy |
1.4% |
| Antiretroviral Therapy |
1.3% |
| Hiv Test Positive |
1.3% |
| Pain |
1.3% |
| Antifungal Prophylaxis |
1.1% |
| Insomnia |
0.8% |
| Medical Diet |
0.7% |
| Diabetes Mellitus |
0.6% |
| Diarrhoea |
0.6% |
| Asthma |
0.6% |
| Anxiety |
0.5% |
|
| Vomiting |
13.7% |
| Rash |
10.2% |
| Pyrexia |
8.6% |
| Weight Decreased |
7.5% |
| Thrombocytopenia |
5.9% |
| Weight Increased |
5.8% |
| Abortion Spontaneous |
4.9% |
| White Blood Cell Count Decreased |
4.1% |
| Viral Load Increased |
4.0% |
| Renal Failure Acute |
3.9% |
| Death |
3.8% |
| Renal Failure |
3.4% |
| Anaemia |
3.2% |
| Myocardial Infarction |
3.1% |
| Oedema Peripheral |
3.1% |
| Nephrolithiasis |
3.0% |
| Abortion Induced |
2.9% |
| Hepatitis |
2.9% |
| Nausea |
2.9% |
| Transaminases Increased |
2.9% |
|
| Interacting |
| Hiv Infection |
45.5% |
| Product Used For Unknown Indication |
11.8% |
| Drug Use For Unknown Indication |
6.9% |
| Infection |
6.5% |
| Hiv Test Positive |
5.7% |
| Chemotherapy |
3.3% |
| Acquired Immunodeficiency Syndrome |
2.4% |
| Antiretroviral Therapy |
2.0% |
| Hypertension |
2.0% |
| Anxiety |
1.6% |
| Cytomegalovirus Chorioretinitis |
1.6% |
| Nausea |
1.6% |
| Neutropenia |
1.6% |
| Asymptomatic Hiv Infection |
1.2% |
| Cholelithiasis |
1.2% |
| Drug Dependence |
1.2% |
| Hepatitis C |
1.2% |
| Antibiotic Prophylaxis |
0.8% |
| Antifungal Prophylaxis |
0.8% |
| Back Pain |
0.8% |
|
| Renal Tubular Necrosis |
19.0% |
| Renal Failure Acute |
14.3% |
| Drug Interaction |
9.5% |
| Renal Failure Chronic |
7.1% |
| Fanconi Syndrome |
4.8% |
| Myalgia |
4.8% |
| Rectal Haemorrhage |
4.8% |
| Renal Tubular Disorder |
4.8% |
| Rhabdomyolysis |
4.8% |
| Adrenal Insufficiency |
2.4% |
| Chest Pain |
2.4% |
| General Physical Health Deterioration |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Hepatic Enzyme Increased |
2.4% |
| Hepatotoxicity |
2.4% |
| International Normalised Ratio Decreased |
2.4% |
| Kidney Fibrosis |
2.4% |
| Lymphangiosis Carcinomatosa |
2.4% |
| Mucosal Inflammation |
2.4% |
| Overdose |
2.4% |
|
